bioAffinity Technologies' CEO, Maria Zannes, will present at Biotech Showcase ™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square.
read moreSan Antonio Business Journal (December 26, 2017) San Antonio-based bioAffinity Technologies Inc. hit the jackpot this summer. In July, I reported that the company had closed on its Series A funding round, raising more than $4 million — $1 million more than it had sought.
read moreSan Antonio Business Journal (December 8, 2017) In an effort to shore up plans to commercialize its initial product, bioAffinity Technologies is adding more scientific and financial firepower to its arsenal. The San Antonio-based biotech is expanding its leadership team.
read moreSAN ANTONIO, TX (Nov. 29, 2017) bioAffinity Technologies, a privately held cancer diagnostics and therapeutics company, today announced the appointments of Stephen Squinto, Ph.D., and Gary Rubin, CPA, to its Board of Directors.
read moreSan Antonio Business Journal (October 31, 2017) bioAffinity Technologies is proud to be chosen by the Texas Business Journals as one of the state's Healthcare Innovators. The recognition for our research that is leading to groundbreaking early cancer diagnostic tests by our dedicated team of scientists is truly appreciated.
read more